Integrated Quantitative Investments LLC Pacira Bio Sciences, Inc. Transaction History
Integrated Quantitative Investments LLC
- $202 Billion
- Q4 2024
A detailed history of Integrated Quantitative Investments LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Integrated Quantitative Investments LLC holds 39,147 shares of PCRX stock, worth $1.04 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
39,147Holding current value
$1.04 Million% of portfolio
0.36%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
49.7MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$212 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$139 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$86.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$59.7 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$52.7 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.21B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...